3 December 2016

Sinclair IS Pharma cuts loss 

22/09/11 Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Value building at Telford Homes  01/12/16

Telford Homes has released another set of reassuring results. Demand remains strong in its specialism of non-prime locations with good transport links and an average selling price in the £500,000 bracket. 

Grant Thornton Quoted Company Awards 2017 01/12/16

The shortlists for the first two categories in the Grant Thornton Quoted Company Awards 2017 have just been released. Read on to see who has been nominated for Chairman and Non-Executive Director of the Year.

Keywords is a video game winner 18/11/16

Keywords Studios continues to perform strongly and has acquired Canada’s Enzyme, which tests the localisation and functional aspects of video games. It will fit nicely with Keywords existing operations in this field and brokers are upgrading earnings by around 5 per cent.

Toople aiming to topple BT 16/11/16

Toople is a new brand in the corporate telecom sector. The company was founded earlier this year by CEO Andy Hollingworth who spent a dozen years at TalkTalk. He sees a major opportunity to grow in the SME market, especially those 5 million or more businesses with under 50 employees.

Kromek detects improved sales 16/11/16

Kromek has been a disappointing investment since listing in 2013. It has interesting technology used in sectors where there are good growth opportunities but so far the company hasn’t delivered the sort of revenues originally targeted. However recent contract wins hold out the prospect of improved visibility.

Wincanton keeps on trucking 10/11/16

Third party logistics provider Wincanton has released interims showing its recovery is firmly on track. The share price responded well, taking the stock close to a five-year high, but there’s still plenty of value on offer with a p/e of less than 8 times current year earnings and a yield of 4.5 per cent.

More News